Insights

Innovative Antibody Platform XBiotech's True Human antibodies, derived from donors with natural immunity, offer a unique and potentially safer therapeutic option that can appeal to pharmaceutical companies seeking next-generation biologics with improved safety and efficacy profiles.

Expanding Clinical Pipeline With ongoing development in oncology, inflammatory conditions, and infectious diseases, XBiotech presents multiple opportunities for licensing, partnerships, and co-development, especially as their therapies progress through clinical trials.

Recent Strategic Moves The appointment of a new board member and the launch of an affordable ERP system indicate the company's strategic focus on governance and operational efficiency, providing reassurance to potential partners and investors.

COVID-19 Response XBiotech's rapid initiation of a discovery program for COVID-19 and development of related therapies such as FLUVID showcase their capabilities in infectious disease research, creating opportunities for collaborations in pandemic preparedness and antiviral therapeutics.

Market Position & Growth Generating between $25M and $50M in revenue with a focused biotechnology niche positions XBiotech as a relevant player for companies looking to expand into novel biologic therapies, particularly those interested in partnering around their pipeline or asset acquisitions.

Similar companies to XBiotech USA, Inc.

XBiotech USA, Inc. Tech Stack

XBiotech USA, Inc. uses 8 technology products and services including SiteCatalyst, CIM Technologies, Open Graph, and more. Explore XBiotech USA, Inc.'s tech stack below.

  • SiteCatalyst
    Analytics
  • CIM Technologies
    Cad & Graphics
  • Open Graph
    Content Management System
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • jQuery Mobile
    Mobile Frameworks
  • Microsoft Windows
    Operating Systems
  • Adobe Acrobat DC
    Rich Text Editors

Media & News

XBiotech USA, Inc.'s Email Address Formats

XBiotech USA, Inc. uses at least 1 format(s):
XBiotech USA, Inc. Email FormatsExamplePercentage
FLast@xbiotech.comJDoe@xbiotech.com
50%
FLast@xbiotech.comJDoe@xbiotech.com
50%

Frequently Asked Questions

Where is XBiotech USA, Inc.'s headquarters located?

Minus sign iconPlus sign icon
XBiotech USA, Inc.'s main headquarters is located at 5217 Winnebago Lane Austin, Texas 78744 United States. The company has employees across 5 continents, including North AmericaAsiaOceania.

What is XBiotech USA, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact XBiotech USA, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XBiotech USA, Inc.'s stock symbol?

Minus sign iconPlus sign icon
XBiotech USA, Inc. is a publicly traded company; the company's stock symbol is XBIT.

What is XBiotech USA, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
XBiotech USA, Inc.'s official website is xbiotech.com and has social profiles on LinkedIn.

How much revenue does XBiotech USA, Inc. generate?

Minus sign iconPlus sign icon
As of March 2026, XBiotech USA, Inc.'s annual revenue is estimated to be $16M.

What is XBiotech USA, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
XBiotech USA, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XBiotech USA, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, XBiotech USA, Inc. has approximately 95 employees across 5 continents, including North AmericaAsiaOceania. Key team members include Chief Scientific Officer: S. S.Vice President Of Manufacturing: M. C.Vp Quality: N. G.. Explore XBiotech USA, Inc.'s employee directory with LeadIQ.

What industry does XBiotech USA, Inc. belong to?

Minus sign iconPlus sign icon
XBiotech USA, Inc. operates in the Biotechnology Research industry.

What technology does XBiotech USA, Inc. use?

Minus sign iconPlus sign icon
XBiotech USA, Inc.'s tech stack includes SiteCatalystCIM TechnologiesOpen GraphjQueryUnderscore.jsjQuery MobileMicrosoft WindowsAdobe Acrobat DC.

What is XBiotech USA, Inc.'s email format?

Minus sign iconPlus sign icon
XBiotech USA, Inc.'s email format typically follows the pattern of FLast@xbiotech.com. Find more XBiotech USA, Inc. email formats with LeadIQ.

When was XBiotech USA, Inc. founded?

Minus sign iconPlus sign icon
XBiotech USA, Inc. was founded in 2005.

XBiotech USA, Inc.

Biotechnology ResearchTexas, United States51-200 Employees

XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology.

Unlike previous generations of antibody therapies, XBiotech’s True Human™ antibodies are 100 percent human, derived from individuals who possess natural immunity to certain diseases. With discovery and clinical programs across multiple disease areas, XBiotech’s True Human™ antibodies have the potential to harness the body’s natural immunity to fight disease with increased safety, efficacy and tolerability.

XBiotech is currently advancing a robust pipeline of antibody therapies to exceed the standards of care in oncology, inflammatory conditions and infectious diseases. The Company's broad pipeline of True Human™ antibodies are able to potentially deliver unmatched safety and efficacy because they are cloned directly from individual donors who possess natural immunity against certain targeted diseases. As such, True Human™ antibodies retain their natural physiology and tolerance profile, having passed the rigors of immune selection in the body.

Section iconCompany Overview

Headquarters
5217 Winnebago Lane Austin, Texas 78744 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
XBIT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    XBiotech USA, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    XBiotech USA, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.